Treatment of non-cardiac chest pain: a controlled trial of hypnotherapy.

Gut
H JonesP J Whorwell

Abstract

Non-cardiac chest pain (NCCP) is an extremely debilitating condition of uncertain origin which is difficult to treat and consequently has a high psychological morbidity. Hypnotherapy has been shown to be effective in related conditions such as irritable bowel syndrome where its beneficial effects are long lasting. This study aimed to assess the efficacy of hypnotherapy in a selected group of patients with angina-like chest pain in whom coronary angiography was normal and oesophageal reflux was not contributory. Twenty eight patients fulfilling the entry criteria were randomised to receive, after a four week baseline period, either 12 sessions of hypnotherapy or supportive therapy plus placebo medication over a 17 week period. The primary outcome measure was global assessment of chest pain improvement. Secondary variables were a change in scores for quality of life, pain severity, pain frequency, anxiety, and depression, as well as any alteration in the use of medication. Twelve of 15 (80%) hypnotherapy patients compared with three of 13 (23%) controls experienced a global improvement in pain (p = 0.008) which was associated with a significantly greater reduction in pain intensity (p = 0.046) although not frequency. Hypnotherapy...Continue Reading

References

Jun 29, 1979·JAMA : the Journal of the American Medical Association·S E EpsteinJ S Borer
Feb 1, 1978·The American Journal of Cardiology·B MarchandiseJ Lesperance
Jul 11, 1992·Lancet·P J WhorwellD G Maxton
May 1, 1991·The American Journal of Medicine·E G HewsonJ E Richter
Nov 1, 1990·Progress in Cardiovascular Diseases·J Chambers, C Bass
Jun 1, 1983·Acta Psychiatrica Scandinavica·A S Zigmond, R P Snaith
Jun 1, 1996·Annals of Internal Medicine·R K Goyal
Jun 1, 1996·Journal of the American College of Cardiology·A ChauhanP M Schofield
Jun 1, 1996·Journal of Clinical Gastroenterology·D A Drossman
Feb 1, 1996·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·L ValentiJ Knapp
Sep 23, 1997·Psychological Medicine·R A MayouC Forfar
May 30, 1998·QJM : Monthly Journal of the Association of Physicians·J Chambers, C Bass
Apr 21, 1999·QJM : Monthly Journal of the Association of Physicians·S G PottsE C Johnstone
May 4, 1999·The American Journal of Medicine·A S van Peski-OosterbaanH G Rooijmans
Apr 24, 2001·The American Journal of Gastroenterology·J Fang, D Bjorkman
May 11, 2002·The American Journal of Gastroenterology·Wendy M GonsalkoralePeter J Whorwell
Jul 30, 2002·Alimentary Pharmacology & Therapeutics·G D EslickN J Talley
Nov 28, 2002·Gastroenterology·Emma Louise CalvertPeter James Whorwell
Oct 23, 2003·Gut·W M GonsalkoraleP J Whorwell
Jan 10, 2004·Health and Quality of Life Outcomes·Stefan HöferNeil Oldridge
Mar 30, 2004·Journal of Psychosomatic Research·Jeanne L Esler, Beth C Bock
Mar 30, 2004·Journal of Psychosomatic Research·Wendy M GonsalkoralePeter J Whorwell
Jan 14, 2005·European Journal of Gastroenterology & Hepatology·Wendy M Gonsalkorale, Peter J Whorwell
Aug 9, 2005·Postgraduate Medical Journal·M HeatleyC Weston
Nov 25, 2005·Alimentary Pharmacology & Therapeutics·P J Whorwell

❮ Previous
Next ❯

Citations

Jul 30, 2010·Current Gastroenterology Reports·Jose M Remes-Troche
Nov 11, 2010·Current Pain and Headache Reports·Nadya M DhananiAdam J Carinci
Mar 1, 2012·Translational Behavioral Medicine·Tiara DillworthMark P Jensen
Feb 17, 2009·The American Journal of Clinical Hypnosis·Mohammad Hassan EmamiHoushang Daneshgar
Jun 5, 2012·The American Journal of Clinical Hypnosis·Gary ElkinsWilliam Fisher
Jun 24, 2008·The International Journal of Clinical and Experimental Hypnosis·Vivien Miller, Peter J Whorwell
Feb 24, 2009·The International Journal of Clinical and Experimental Hypnosis·Helen R CarruthersPeter J Whorwell
Feb 26, 2010·The International Journal of Clinical and Experimental Hypnosis·Alexandra DufresneIsabelle Marc
Nov 17, 2012·The International Journal of Clinical and Experimental Hypnosis·Charles D GersonMary-Joan Gerson
Nov 4, 2008·Menopause : the Journal of the North American Menopause Society·Elizabeth A AsburyPeter Collins
Sep 13, 2006·Gut·O S Palsson, W E Whitehead
Jan 1, 2008·Gastroenterology Research and Practice·C Shekhar, P J Whorwell
Jun 24, 2009·Digestion·I M ModlinUNKNOWN Vevey NERD Consensus Group
Nov 15, 2008·World Journal of Gastroenterology : WJG·Giuseppe ChiarioniWilliam E Whitehead
Nov 26, 2010·The International Journal of Clinical and Experimental Hypnosis·Isabelle MarcEdzard Ernst
Feb 19, 2014·Paediatric Respiratory Reviews·Joshua J McBrideRan D Anbar
Aug 12, 2014·Drugs·Gehanjali Amarasinghe, Daniel Sifrim
May 22, 2009·The International Journal of Clinical and Experimental Hypnosis·Vivien Miller, Peter J Whorwell
Mar 2, 2012·Women's Health·Raghubinder S GillNicolas J Talley
Dec 9, 2009·Harvard Review of Psychiatry·Stephen E NicolsonTheodore A Stern
Mar 22, 2012·European Journal of Gastroenterology & Hepatology·Michael ShapiroEfrat Broide
Oct 29, 2008·Journal of Pediatric Gastroenterology and Nutrition·Arine M Vlieger, Marc A Benninga
Mar 28, 2008·Journal of Clinical Gastroenterology·Ronnie Fass, Tomás Navarro-Rodriguez
Nov 26, 2009·Expert Review of Gastroenterology & Hepatology·James R GoodhandDavid S Rampton
Aug 1, 2013·Expert Review of Gastroenterology & Hepatology·Anand R Kumar, Philip O Katz
Feb 8, 2014·Gastroenterology Clinics of North America·Marcelo F Vela
Nov 26, 2015·Alimentary Pharmacology & Therapeutics·N GeorgeR Fass
Oct 30, 2012·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Olafur S Palsson, William E Whitehead
Nov 9, 2010·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Amindra S Arora, David A Katzka
Aug 14, 2009·Gastroentérologie Clinique Et Biologique·R Jian
Aug 30, 2008·Disease-a-month : DM·Sami R Achem
May 27, 2008·Journal of Psychosomatic Research·Peter J Whorwell
Oct 24, 2008·Alimentary Pharmacology & Therapeutics·A GasiorowskaR Fass
Feb 18, 2010·Contemporary Hypnosis : the Journal of the British Society of Experimental and Clinical Hypnosis·Brenda L StoelbDavid R Patterson
Oct 15, 2013·Annals of the New York Academy of Sciences·Anne Lund KrarupSami R Achem
Nov 15, 2011·Alimentary Pharmacology & Therapeutics·T HershcoviciR Fass
May 13, 2010·Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus·J L KieblesL Keefer
Apr 1, 2015·Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus·M E RiehlL Keefer
Nov 26, 2008·Gastroenterology Clinics of North America·Sami R Achem
Sep 3, 2013·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Enrique Coss-AdameSatish S C Rao
Mar 5, 2015·Alimentary Pharmacology & Therapeutics·V MillerP J Whorwell
Jul 16, 2015·Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus·M E RiehlL Keefer
Aug 13, 2015·The American Journal of Clinical Hypnosis·Olafur S Palsson
Jun 6, 2015·The American Journal of Clinical Hypnosis·Megan E Riehl, Laurie Keefer

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.